Clinical Trial

ESKALE: descriptive study of patients with treatment-resistant depression treated with esketamine, within the framework of the cohort ATU, the post-ATU program or the post-marketing period

Target Enrollment
Not specified
Study Type
interventional
Design
Randomized

Study Protocol

Preparation

sessions

Dosing

sessions

Integration

sessions

Therapeutic Protocol

Manualized psychotherapy included

Study Details

  • Type
    interventional
  • Design
    Randomized

Related Publications

Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study

Published

Your Library